Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antibodies Induced by Smallpox Vaccination after at Least 45 Years Cross-React with and In Vitro Neutralize Mpox Virus: A Role for Polyclonal B Cell Activation?
Mariotti S, Venturi G, Chiantore MV, Teloni R, De Santis R, Amendola A, Fortuna C, Marsili G, Grilli G, Lia MS, Kiros ST, Lagi F, Bartoloni A, Iacobino A, Cresta R, Lastilla M, Biselli R, Di Bonito P, Lista F, Nisini R. Mariotti S, et al. Among authors: kiros st. Viruses. 2024 Apr 17;16(4):620. doi: 10.3390/v16040620. Viruses. 2024. PMID: 38675961 Free PMC article.
Oral microbiota signatures associated with viremia and CD4 recovery in treatment-naïve HIV-1-infected patients.
Nannini G, Di Gloria L, Russo E, Sterrantino G, Kiros ST, Coppi M, Niccolai E, Baldi S, Ramazzotti M, Di Pilato V, Lagi F, Bartolucci G, Rossolini GM, Bartoloni A, Amedei A. Nannini G, et al. Among authors: kiros st. Microbes Infect. 2024 Apr 16:105339. doi: 10.1016/j.micinf.2024.105339. Online ahead of print. Microbes Infect. 2024. PMID: 38636822 Free article.
Bendamustine impairs humoral but not cellular immunity to SARS-CoV-2 vaccination in rituximab-treated B-cell lymphoma-affected patients.
Vanni A, Salvati L, Mazzoni A, Lamacchia G, Capone M, Francalanci S, Kiros ST, Cosmi L, Puccini B, Ciceri M, Sordi B, Rossolini GM, Annunziato F, Maggi L, Liotta F. Vanni A, et al. Among authors: kiros st. Front Immunol. 2023 Dec 1;14:1322594. doi: 10.3389/fimmu.2023.1322594. eCollection 2023. Front Immunol. 2023. PMID: 38106404 Free PMC article.
Fourth Dose of mRNA COVID-19 Vaccine Transiently Reactivates Spike-Specific Immunological Memory in People Living with HIV (PLWH).
Lamacchia G, Salvati L, Kiros ST, Mazzoni A, Vanni A, Capone M, Carnasciali A, Farahvachi P, Lagi F, Di Lauria N, Rocca A, Colao MG, Liotta F, Cosmi L, Rossolini GM, Bartoloni A, Maggi L, Annunziato F. Lamacchia G, et al. Among authors: kiros st. Biomedicines. 2022 Dec 15;10(12):3261. doi: 10.3390/biomedicines10123261. Biomedicines. 2022. PMID: 36552017 Free PMC article.
Clinical and Immunological Features of SARS-CoV-2 Breakthrough Infections in Vaccinated Individuals Requiring Hospitalization.
Lamacchia G, Mazzoni A, Spinicci M, Vanni A, Salvati L, Peruzzi B, Bencini S, Capone M, Carnasciali A, Farahvachi P, Rocca A, Kiros ST, Graziani L, Zammarchi L, Mencarini J, Colao MG, Caporale R, Liotta F, Cosmi L, Rossolini GM, Bartoloni A, Maggi L, Annunziato F. Lamacchia G, et al. Among authors: kiros st. J Clin Immunol. 2022 Oct;42(7):1379-1391. doi: 10.1007/s10875-022-01325-2. Epub 2022 Jul 9. J Clin Immunol. 2022. PMID: 35809212 Free PMC article.
Long-term SARS-CoV-2 Asymptomatic Carriage in an Immunocompromised Host: Clinical, Immunological, and Virological Implications.
Spinicci M, Mazzoni A, Coppi M, Antonelli A, Salvati L, Maggi L, Basile G, Graziani L, Di Lauria N, Di Pilato V, Kiros ST, Beccastrini E, Saccardi R, Angileri M, Cecchi M, Cusi MG, Rossolini GM, Annunziato F, Bartoloni A, Parronchi P. Spinicci M, et al. Among authors: kiros st. J Clin Immunol. 2022 Oct;42(7):1371-1378. doi: 10.1007/s10875-022-01313-6. Epub 2022 Jul 2. J Clin Immunol. 2022. PMID: 35779200 Free PMC article.
Effects of viremia and CD4 recovery on gut "microbiome-immunity" axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy.
Russo E, Nannini G, Sterrantino G, Kiros ST, Di Pilato V, Coppi M, Baldi S, Niccolai E, Ricci F, Ramazzotti M, Pallecchi M, Lagi F, Rossolini GM, Bartoloni A, Bartolucci G, Amedei A. Russo E, et al. Among authors: kiros st. World J Gastroenterol. 2022 Feb 14;28(6):635-652. doi: 10.3748/wjg.v28.i6.635. World J Gastroenterol. 2022. PMID: 35317423 Free PMC article.
SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies.
Mazzoni A, Vanni A, Spinicci M, Lamacchia G, Kiros ST, Rocca A, Capone M, Di Lauria N, Salvati L, Carnasciali A, Mantengoli E, Farahvachi P, Zammarchi L, Lagi F, Colao MG, Liotta F, Cosmi L, Maggi L, Bartoloni A, Rossolini GM, Annunziato F. Mazzoni A, et al. Among authors: kiros st. J Clin Invest. 2022 Mar 15;132(6):e157990. doi: 10.1172/JCI157990. J Clin Invest. 2022. PMID: 35139036 Free PMC article.
Comparison of the efficacy, safety and durability of a switch to co-formulated RPV/TDF-TAF/FTC or DTG/ABC/3TC in virologically-suppressed HIV-1-infected patients in a single Italian centre: a cohort data analysis.
Lagi F, Botta A, Kiros ST, Meli M, Borchi B, Cavallo A, Pozzi M, Bartoloni A, Sterrantino G. Lagi F, et al. Among authors: kiros st. Int J Antimicrob Agents. 2022 Jan;59(1):106465. doi: 10.1016/j.ijantimicag.2021.106465. Epub 2021 Oct 23. Int J Antimicrob Agents. 2022. PMID: 34699933
17 results